Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

The treatment improved hair thickness, shine, and reduced hair loss effectively.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Different ethnic groups have unique hair growth patterns, with African hair growing slower and less dense, Asian hair growing fast but sparse, and Caucasian hair being densest; men are more likely to experience hair loss than women.

Platelet-Rich Plasma (PRP) treatment can significantly increase hair count and thickness in people with Androgenetic Alopecia (AGA) with minimal side effects.

Placental stem cell exosome therapy improves hair growth and reduces hair loss.

New 5% minoxidil solution improves scalp hydration, reduces redness, and may be safer for sensitive users.

Acne treatment with isotretinoin increases the presence of p53, a protein, in skin and oil glands, which may help reduce acne severity.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Combining fractional CO2 laser with topical dutasteride is more effective for treating male hair loss than using the laser alone.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Oral clindamycin and rifampicin are the most effective treatments for Folliculitis decalvans.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

Hair loss severity is linked to depression, not anxiety, in Filipino men, with older, less educated men with more hair loss at higher risk.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Dr. SKS Hair Booster Serum effectively treats hair loss in women with PCOS.

Non-obese women with hair loss have higher heart disease risk.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

PRP therapy is more effective than minoxidil for treating hair loss from androgenetic alopecia.

PRP is effective for treating hair loss, especially with other treatments.